SAN DIEGO--(BUSINESS WIRE)--Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R) and interleukin-18 binding ...
BioStat.AI is built on the foundation of EDETEK's flagship platforms, CONFORM™ and eClinical, and leverages advanced AI technologies including large language models (LLMs), machine learning, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback